Corporate Profile
In 2010, 60 Degrees Pharmaceuticals began its mission to address vector-borne diseases through the development of innovative new treatments and preventive medicines. To this day, our mission continues. We value the needs of patients and providers in our approach to developing treatments that make a positive difference in people's lives. With the successful launch of tafenoquine for malaria prevention, we are researching the utility of tafenoquine to address additional challenges in vector-borne diseases.